| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 4, 2007
Accepted on August 25, 2008
From the Bristol Heart Institute, University of Bristol, UK.
* To whom correspondence should be addressed. E-mail: A.Newby{at}bris.ac.uk.
Abstract—Matrix metalloproteinases (MMPs) can degrade strength-giving collagens and other structural proteins of the arterial extracellular matrix. Overproduction of MMPs by monocyte/macrophages could therefore promote atherosclerotic plaque rupture and myocardial infarction. Freshly-recruited monocyte macrophages appear to use a prostaglandin (PG)-dependent pathway to coordinately upregulate a broad and potentially highly-destructive spectrum of MMPs. Differentiated macrophages rely on a series of distinct pathways to selectively upregulate groups of MMPs. Moreover, recent evidence suggests that different macrophage phenotypes express characteristically different spectra of MMPs and their inhibitors. New therapies may result from targeting matrix MMP overproduction.
This article has been cited by other articles:
![]() |
Z. Mallat Matrix Metalloproteinase-8 and the Regulation of Blood Pressure, Vascular Inflammation, and Atherosclerotic Lesion Growth Circ. Res., October 23, 2009; 105(9): 827 - 829. [Full Text] [PDF] |
||||
![]() |
B. Chu, M. S. Ferguson, H. Chen, D. S. Hippe, W. S. Kerwin, G. Canton, C. Yuan, and T. S. Hatsukami Cardiac Magnetic Resonance Features of the Disruption-Prone and the Disrupted Carotid Plaque J. Am. Coll. Cardiol. Img., July 1, 2009; 2(7): 883 - 896. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |